These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2278518)

  • 1. [Hypertensive action of 5-(omega-aminoalkyl)aminoisoxazole: synthesis and testing of compounds with a sulfamide or carboxyl group on the end of side chain].
    Dannhardt G; Dominiak P; Laufer S
    Arch Pharm (Weinheim); 1990 Aug; 323(8):517-9. PubMed ID: 2278518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertensive acting 5-(beta-aminoethyl)aminoisoxazoles: synthesis and screening of derivatives with with partially rigid C-5 side chains and omega-position heterocyclics].
    Dannhardt G; Dominiak P; Laufer S
    Arch Pharm (Weinheim); 1990 Sep; 323(9):571-8. PubMed ID: 2288479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.
    Murugesan N; Tellew JE; Gu Z; Kunst BL; Fadnis L; Cornelius LA; Baska RA; Yang Y; Beyer SM; Monshizadegan H; Dickinson KE; Panchal B; Valentine MT; Chong S; Morrison RA; Carlson KE; Powell JR; Moreland S; Barrish JC; Kowala MC; Macor JE
    J Med Chem; 2002 Aug; 45(18):3829-35. PubMed ID: 12190306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
    Wang S; Yan J; Wang J; Chen J; Zhang T; Zhao Y; Xue M
    Eur J Med Chem; 2010 Jun; 45(6):2663-70. PubMed ID: 20189693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of potent, isoxazole-containing renin inhibitors.
    Fournier PA; Arbour M; Cauchon E; Chen A; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Grimm E; Han Y; Houle R; Lacombe P; Lévesque JF; MacDonald D; Mackay B; McKay D; Percival MD; Ramtohul Y; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2670-4. PubMed ID: 22450130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors.
    Zhao H; Liu G; Xin Z; Serby MD; Pei Z; Szczepankiewicz BG; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5543-6. PubMed ID: 15482920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines.
    Confalone PN; Jin F; Mousa SA
    Bioorg Med Chem Lett; 1999 Jan; 9(1):55-8. PubMed ID: 9990456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064.
    Akwabi-Ameyaw A; Bass JY; Caldwell RD; Caravella JA; Chen L; Creech KL; Deaton DN; Jones SA; Kaldor I; Liu Y; Madauss KP; Marr HB; McFadyen RB; Miller AB; Navas F; Parks DJ; Spearing PK; Todd D; Williams SP; Wisely GB
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4339-43. PubMed ID: 18621523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological activity of new heterocyclic amides of 5-amino-3-methylisoxazole-4-carboxylic acid.
    Ryng S; Zimecki M; Fedorowicz A; Koll A
    Pol J Pharmacol; 1999; 51(3):257-62. PubMed ID: 10600040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of some 1-piperazinecarboxalic acid ethyl ester derivatives as possible antifilarial and antihypertensive agents.
    Das PC; Patra BB; Chaudhuri SB; Basu UP
    J Med Chem; 1971 Sep; 14(9):890-1. PubMed ID: 5140022
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.
    Palin R; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Maclean J; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; McArthur D; McGregor D; McLuskey H; Neagu I; Neale S; Nisbet LA; Ohlmeyer M; Pham Q; Ratcliffe P; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G
    Bioorg Med Chem Lett; 2011 Feb; 21(3):892-8. PubMed ID: 21236666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertensive effects and structure-activity relationships of 5-omega-aminoalkyl isoxazoles.
    Dannhardt G; Dominiak P; Laufer S
    Arzneimittelforschung; 1993 Apr; 43(4):441-4. PubMed ID: 8494574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action.
    Olson RE; Sielecki TM; Wityak J; Pinto DJ; Batt DG; Frietze WE; Liu J; Tobin AE; Orwat MJ; Di Meo SV; Houghton GC; Lalka GK; Mousa SA; Racanelli AL; Hausner EA; Kapil RP; Rabel SR; Thoolen MJ; Reilly TM; Anderson PS; Wexler RR
    J Med Chem; 1999 Apr; 42(7):1178-92. PubMed ID: 10197962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics.
    Murugesan N; Gu Z; Fadnis L; Tellew JE; Baska RA; Yang Y; Beyer SM; Monshizadegan H; Dickinson KE; Valentine MT; Humphreys WG; Lan SJ; Ewing WR; Carlson KE; Kowala MC; Zahler R; Macor JE
    J Med Chem; 2005 Jan; 48(1):171-9. PubMed ID: 15634011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
    Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent methodologies toward the synthesis of valdecoxib: a potential 3,4-diarylisoxazolyl COX-II inhibitor.
    Dadiboyena S; Nefzi A
    Eur J Med Chem; 2010 Nov; 45(11):4697-707. PubMed ID: 20724040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antihypertensive screening of new derivatives of quinazolines linked with isoxazole.
    Rahman MU; Rathore A; Siddiqui AA; Parveen G; Shahar Yar M
    Biomed Res Int; 2014; 2014():739056. PubMed ID: 25013797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 3-aminoisoxazoles via the addition-elimination of amines on 3-bromoisoxazolines.
    Girardin M; Alsabeh PG; Lauzon S; Dolman SJ; Ouellet SG; Hughes G
    Org Lett; 2009 Mar; 11(5):1159-62. PubMed ID: 19209874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic liquid-supported synthesis of sulfonamides and carboxamides.
    Muthayala MK; Chhikara BS; Parang K; Kumar A
    ACS Comb Sci; 2012 Jan; 14(1):60-5. PubMed ID: 22013985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and pharmacologic activity of N-oxides of 4'-(benzotriazol-2-yl-phenylalkanoic and -phenoxyalkanoic acids].
    Boido A; Vazzana I; Sparatore F; Cappello B; Diurno V; Matera C; Marrazzo R; Russo S; Cenicola ML; Marmo E
    Farmaco; 1989 Mar; 44(3):257-77. PubMed ID: 2789055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.